Turkey Neurology Devices Market Analysis

Turkey Neurology Device Market Executive Summary

Turkey's Neurology Device Market size is at around $101 Mn in 2022 and is projected to reach $191 Mn in 2030, exhibiting a CAGR of 8.3% during the forecast period. Neurology in Turkey is well-developed, with a strong tradition of clinical practice and research. The country has a number of highly regarded academic centers and healthcare institutions that provide advanced medical care to patients with neurological conditions. However, the overall healthcare delivery in Turkey is a matter of ongoing public debate, with some challenges related to access, quality, and cost. Nevertheless, the country has made significant investments in improving its healthcare infrastructure and services in recent years, and it continues to strive towards providing high-quality care to its citizens.

The state of neurological diseases in Turkey is similar to that of other countries, with a high burden of conditions such as stroke, Alzheimer's disease, and epilepsy. There is a well-developed healthcare system in Turkey, with a mix of public and private facilities that provide treatment for neurological diseases. The treatment of neurological diseases in Turkey typically involves a combination of medication, rehabilitation, and lifestyle changes. There are also specialized centers for the treatment of specific neurological conditions, such as Parkinson's disease, multiple sclerosis, and spinal cord injuries. In recent years, there has been a focus on improving access to advanced diagnostic techniques and treatments, such as deep brain stimulation, for patients with neurological disorders in Turkey.  Some of the most common neurological conditions in Turkey include Alzheimer's disease, Parkinson's disease, epilepsy, migraine, and multiple sclerosis. Diagnosis and treatment of neurological diseases in Turkey are carried out by a team of healthcare professionals, including neurologists, neurosurgeons, and other specialists. The diagnostic process usually involves a detailed medical history and examination, along with various tests such as imaging studies, electroencephalography (EEG), and nerve conduction studies.

Treatment options for neurological diseases depend on the specific condition and may include medications, surgery, physical therapy, and rehabilitation. In general, patients in Turkey have access to a range of modern and effective treatments for neurological conditions. However, like in many other countries, the cost of healthcare can be a barrier for some people, and there are ongoing efforts to improve access to care and ensure that all patients receive the treatments they need. Various neurological devices are used for interventional and neurostimulation treatment for different conditions -

• Stroke: Thrombectomy devices, Intra-arterial thrombolysis devices
• Epilepsy: Vagus nerve stimulation (VNS) devices, Responsive neurostimulation (RNS) devices, Deep brain stimulation (DBS) devices
• Alzheimer's: Transcranial magnetic stimulation (TMS) devices, Transcranial direct current stimulation (tDCS) devices
• Chronic Pain: Spinal cord stimulation (SCS) devices, Peripheral nerve stimulation (PNS) devices, High-frequency spinal cord stimulation (HF-SCS) devices

Market Dynamics

Market Growth Drivers

Changes in government laws and regulations regulating the payment of medical devices, for example, might have a considerable impact on neurology device sales. The economic climate, including changes in GDP, inflation, and the exchange rate, can affect individuals and healthcare institutions' purchasing power, hence influencing demand for medical devices. The medical device industry's rapid technological improvements can result in the launch of new and improved goods, which can stimulate sales. The existence of a high number of domestic and international firms in the market might result in severe competition, affecting individual company sales. Demographic changes, such as an aging population and a rise in the incidence of neurological illnesses, might boost demand for neurology devices. The amount of awareness and education regarding neurological problems and therapies available in Turkey can have an impact on the demand for neurology devices. The regulatory framework in Turkey, including approvals and certifications required for medical devices, has had an impact on the sales of local businesses in the neurology devices industry.

Market Restraints

 The cost of neurology equipment might be substantial, limiting their access to some patients and limiting the market growth. In Turkey, reimbursement for neurological devices by public and private insurance may be limited, limiting their accessibility for some patients. There may be a paucity of skilled professionals in Turkey who can implant and use neurology devices, limiting market expansion. The regulatory environment for medical devices in Turkey can be complex and difficult, which may limit the introduction of novel neurological equipment and impede the market growth.

Competitive Landscape

Key Players

• Medtronic
• Boston Scientific
• St. Jude Medical
• B. Braun
• Integra LifeSciences

Healthcare Policies and Regulatory Landscape

In Turkey, the regulatory body for medical devices, including neurology devices, is the Ministry of Health Medical Devices and Pharmaceuticals Institution. The institution is responsible for evaluating, registering, and monitoring the safety, quality, and efficacy of medical devices in the country. They also oversee the import and export of medical devices and enforce regulations to ensure that medical devices available in the Turkish market meet established standards.

Reimbursement Scenario

The National Health Insurance manages the reimbursement of neurology equipment, and they are responsible for covering the price of medical devices, including neurology devices, for those enrolled in the statutory health insurance system. The reimbursement procedure is based on a set of criteria, which includes the patient's diagnosis, the type of device utilized, and the device's cost. Patients may be asked to pay a percentage of the device's cost in some situations, and some devices may not be fully covered by the insurance system. The neurology device must be approved by the National Agency for the Safety of Medicines and meet certain medical criteria in order to be reimbursed. A letter from the patient's healthcare provider is also required.